ValiRx plc (AIM:VAL)

London · Delayed Price · Currency is GBP · Price in GBX

0.3000

-0.0250 (-7.69%)

Mar 5, 2026, 10:19 AM GMT

Revenue by Segment

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Drug Development	49.78K	9.60K	-	-	-
Drug Development Growth	418.49%	-	-	-	-
Total	49.78K	9.60K	-	-	-
Total Growth	418.49%	-	-	-	-

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United Kingdom	49.78K	9.60K	-	-	-
United Kingdom Growth	418.49%	-	-	-	-
Total	49.78K	9.60K	-	-	-
Total Growth	418.49%	-	-	-	-

Source: S&P Global Market Intelligence.